Table 2 |
||||||||||
|
Immunostaining of osteosarcoma-derived cell lines |
||||||||||
|
|
|
|
Cell line |
|
|
|||||
|
|
||||||||||
|
OSA-01 |
OSA-02 |
OSA-03 |
OSA-05 |
Saos-2 |
||||||
|
Antigen |
% |
IR |
% |
IR |
% |
IR |
% |
IR |
% |
IR |
|
|
||||||||||
|
Desmin |
+++ |
+ |
++ |
++ |
+++ |
++ |
++ |
+ |
++ |
+ |
|
S-100 |
+++ |
+ |
+++ |
+ |
++ |
+ |
+++ |
++ |
+++ |
+ |
|
Vimentin |
++ |
+ |
++ |
+ |
+++ |
++ |
+++ |
+++ |
++ |
++ |
|
Nestin |
++ |
++ |
++ |
++ |
+++ |
+++ |
- |
- |
+ |
+++ |
|
CD133 |
+++ |
++ |
+++ |
+++ |
+++ |
+++ |
+++ |
++ |
+++ |
+++ |
|
|
||||||||||
|
% |
% |
% |
% |
% |
||||||
|
|
||||||||||
|
Nestin/CD133 co-expression |
++ |
++ |
+++ |
- |
+ |
|||||
|
|
||||||||||
|
Expression of nestin, CD133 and other proteins was examined on cell cultures of osteosarcoma-derived cell lines using indirect immunofluorescence. With the exception of the nestin-negative OSA-05 cell line, all cell lines showed even immunoreactivity for the detected antigens. Percentage of positive cells in cell populations (%: -, 0%; +/-, <2 %; +, 2–10 %; ++, 11–50 %; +++, 51–100 %) and intensity of immunostaining (IR: -, none; +, weak; ++, medium; +++, strong) were evaluated. Saos-2 cell line was originally used as a control osteosarcoma cell line for the CD133 staining. |
||||||||||
|
Veselska et al. BMC Cancer 2008 8:300 doi:10.1186/1471-2407-8-300 |
||||||||||